What you missed this week in women's health
This week's must-read stories included:
The use of hair dyes, bleach, relaxers, and mousse was associated with lower levels of sex steroid hormones in pregnant women, according to a new Rutgers study.
A home kit to detect urinary tract infections (UTIs) like Candida albicans from vaginal fluids on sanitary napkins and tampons could soon enter the clinical phase.
The Society for Maternal-Fetal Medicine has announced its upcoming 2022 annual meeting will now be virtual.
Do you expect new technology, like vNOTES, to revive the industry's enthusiasm for single-port surgery?
While it has been nearly 50 years since vaginal dilators were introduced as a therapy to decrease VS, the medical community still knows very little about the potential impact on long-term outcomes.
An experimental blood test uses plasma cell-free RNA (cfRNA) to accurately predict preeclampsia as early as 16 weeks.
Identification and management of patients at increased risk for breast cancer
February 5th 2025With breast cancer being the most diagnosed invasive cancer in the United States, OB-GYN practitioners play a crucial role in identifying high-risk patients and guiding them through screening, prevention, and risk-reduction strategies.
Read More
AI helps improve detection of congenital heart defects on prenatal ultrasounds
January 31st 2025AI-assisted software improves clinicians' detection of congenital heart defects in prenatal ultrasounds, enhancing accuracy, confidence, and speed, according to a study presented at SMFM's Annual Pregnancy Meeting.
Read More